Onconetix, Inc. Gain (Loss) on Extinguishment of Debt
Onconetix, Inc. (ONCO) reported Gain (Loss) on Extinguishment of Debt of -$5.38 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-03-13
- Onconetix, Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-12-31 was $0.00.
- Onconetix, Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-09-30 was -$5.38M.
- Onconetix, Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-03-31 was $490.00K.
- Onconetix, Inc. gain (loss) on extinguishment of debt for the quarter ending 2023-12-31 was $0.00.
- Onconetix, Inc. gain (loss) on extinguishment of debt for fiscal 2025 was -$5.38M.
- Onconetix, Inc. gain (loss) on extinguishment of debt for fiscal 2023 was -$490.00K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$5.38M derived: sum of 2 quarters · filed 2026-03-13 | -$5.38M 10-K · filed 2026-03-13 | |
| 2025-09-30 | -$5.38M 10-Q · filed 2025-11-13 | -$5.38M 10-Q · filed 2025-11-13 | ||
| 2024-03-31 | $490.00K 10-Q · filed 2024-05-20 | $490.00K derived: sum of 2 quarters · filed 2025-06-02 | $0.00 derived: sum of 3 quarters · filed 2025-06-02 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-02 | -$490.00K derived: sum of 2 quarters · filed 2025-06-02 | -$490.00K 10-K · filed 2025-06-02 | |
| 2023-09-30 | -$490.00K 10-Q · filed 2024-12-10 | -$490.00K 10-Q · filed 2024-12-10 | ||
| 2023-09-29 | $490.00K 10-K · filed 2024-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |